TCT-26 Long-Term Event Rates for Left Atrial Appendage Closure with WATCHMAN: PROTECT AF 5 Year and PREVAIL 3 Year Follow-up

Left atrial appendage closure (LAAC) with the Watchman Device (Boston Scientific, MN) is an alternative to warfarin for stroke risk reduction in high risk non-valvular atrial fibrillation (NVAF) patients. This analysis presents the most updated clinical event rates over the longest course of